Antiviral agent
Grant
US12576117B2
Kind: B2
Mar 17, 2026
Assignee
TOHOKU UNIVERSITY
Inventors
Haruki Kitazawa, Hisashi Aso, Wakako Ohtsubo
Abstract
A problem of the invention is to provide an antiviral agent containing as an active ingredient a probiotic which effectively exhibits an antiviral effect also on combined infection with a virus and a pathogenic bacterium. An agent containing one, two or more Lactobacillus strains which have 16S rRNA gene having an identity of at least 90% with the nucleotide sequence of SEQ ID NO: 1 and which have the action of enhancing the expression of an antiviral factor and/or the action of reducing the expression of a downregulator of an antiviral factor is used as an antiviral agent.
CPC Classifications
A61K 35/747
A61K 9/0056
A61K 2035/115
A61P 31/14
A61P 31/12
C12N 1/205
C12N 15/113
C12N 1/20
C12R 2001/25
C12R 2001/225
A23V 2002/00
A23K 10/18
Y02A 50/30
A23L 33/135
Filing Date
2021-05-28
Application No.
17925333
Claims
12